Welcome to BC PharmaCare's public survey of drugs being reviewed for coverage. This survey is for roflumilast cream (Zoryve) for the topical treatment of mild to moderate atopic dermatitis in patients 6 years of age and older, with inadequate response, intolerance, or contraindications to topical corticosteroids.